"Many of my patients with multidrug-resistant recurrent urinary tract infections have tried multiple antibiotics for years without success," said Liz D'Antonio, CRNP, director of clinical research, Anne Arundel Urology. " A vaccine presents a new approach that could offer new hope for these patients. We eagerly await the results of the next studies as it hopefully moves toward approval."
"While the search for new antibiotics continues, several studies have highlighted that vaccines also have benefits against AMR. By reducing cases of disease, they slow the rise of drug-resistant pathogens, because the microbes have fewer opportunities to multiply and evolve."